DrugsControl Media Services

News Detail

Tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes: Eli Lilly (28-04-2023)

View Details

Source : CNN Health
brand safety-nsf health issues brand safety-nsf sensitive business and industry sectors business economy and trade chronic diseases companies diabetes diet and nutrition diet nutrition and fitness diseases and disorders domestic alerts domestic-health and science eli lilly & co endocrine system disorders government organizations - us health and medical iab-business and finance iab-diabetes iab-diseases and conditions iab-endocrine and metabolic diseases iab-food & drink iab-healthy cooking and eating iab-healthy living iab-industries iab-medical health iab-pharmaceutical drugs iab-pharmaceutical industry iab-weight loss international alerts international-health and science obesity pharmaceutical industry pharmaceuticals pharmaceuticals and prescription drugs us department of health and human services us federal departments and agencies us food and drug administration weight loss diets

Related News